Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D00HCC
|
|||
Former ID |
DNC010054
|
|||
Drug Name |
1-(2-phenoxyphenyl)piperazine
|
|||
Synonyms |
1-(2-phenoxyphenyl)piperazine; CHEMBL573532; SCHEMBL546735; VAXHGPCUAFNAQS-UHFFFAOYSA-N; 1-(2-Phenoxy-phenyl)-piperazine; ZINC37635596; BDBM50299785
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C16H18N2O
|
|||
Canonical SMILES |
C1CN(CCN1)C2=CC=CC=C2OC3=CC=CC=C3
|
|||
InChI |
1S/C16H18N2O/c1-2-6-14(7-3-1)19-16-9-5-4-8-15(16)18-12-10-17-11-13-18/h1-9,17H,10-13H2
|
|||
InChIKey |
VAXHGPCUAFNAQS-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1... Bioorg Med Chem Lett. 2009 Dec 1;19(23):6604-7. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.